MorphoSys AG
MorphoSys AG (MOR) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
mor · stock forecast · 10 analysts (3M) · FMP · updated Oct 6, 2025
Analyst Rating & Consensus
Based on 10 Wall Street analysts in the past 3 months
Buy
10 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $18.96
Short-Term Price Prediction
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · MOR · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2024-03-14 | Wells Fargo | Downgrade ↓ | Overweight→Equal Weight |
| 2024-02-05 | Wells Fargo | Maintains | Overweight→Overweight |
| 2024-01-19 | Morgan Stanley | Downgrade ↓ | Overweight→Equal Weight |
| 2024-01-16 | Morgan Stanley | Downgrade ↓ | Overweight→Equal Weight |
| 2023-12-15 | Wells Fargo | Maintains | Overweight→Overweight |
| 2023-12-05 | JP Morgan | Maintains | Overweight→Overweight |
| 2023-11-22 | Goldman Sachs | Maintains | Neutral→Neutral |
| 2023-11-21 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2023-10-13 | Morgan Stanley | Upgrade ↑ | Underweight→Overweight |
| 2023-10-12 | Morgan Stanley | Upgrade ↑ | Underweight→Overweight |
Wall Street analysts have recently issued updated ratings on MorphoSys AG (MOR) stock. Of the recent 40 rating actions, 10 were upgrades and 15 were downgrades. 10 analysts currently cover MOR.
Analyst Recommendation Trends
MOR analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$220M
↓ 46.8% YoY
Revenue Next Year
$324M
↑ 47.2% YoY
EPS This Year
$-2.38
EPS Next Year
$-1.37
↓ 42.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast MOR EPS of $-2.38 for the current fiscal year, based on estimates from 4 analysts. The MOR revenue forecast is $220M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The MOR stock forecast is supported by two independent data sources: analyst consensus ratings from 10 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus MOR price target is $0.00 (+0.0% upside), with an analyst consensus of Buy.
MorphoSys AG trades on NASDAQ under the ticker MOR. The MOR stock outlook for 2027 is broadly positive, supported by a Buy consensus among 50% of covering analysts.
Frequently asked questions
MOR forecast · 8 questionsAccording to 10 Wall Street analysts, the average 12-month MOR price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $18.96.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.